Please login to the form below

Not currently logged in
Email:
Password:

Immune Design

This page shows the latest Immune Design news and features for those working in and with pharma, biotech and healthcare.

Merck bulks up in cancer with $2.2bn Peloton buy

Merck bulks up in cancer with $2.2bn Peloton buy

It is the second pipeline-boosting deal for Merck in three months, coming after it paid $300m for cancer vaccine developer Immune Design.

Latest news

  • Merck & Co to buy IO specialists Immune Design for $300m Merck & Co to buy IO specialists Immune Design for $300m

    US giant looks to next generation technology. Immunotherapy leader Merck &Co/MSD is to acquire a vaccine specialist firm Immune Design for $300m. ... last went shopping for a new bolt-on technology. Immune Design is a late-stage immunotherapy company

  • Genital herpes vaccine candidate promising in phase II Genital herpes vaccine candidate promising in phase II

    Other companies working on HSV-2 vaccines include Sanofi/Immune Design, Agenus, Tomegavax and Australian company Admedus, which has also just reported preliminary phase II data on its candidate.

  • Vical's genital herpes vaccine flunks trial Vical's genital herpes vaccine flunks trial

    Both a monovalent and a bivalent version of the vaccine against Herpes simplex virus type 2 (HSV-2) - which are formulated with Vical's adjuvant Vaxfectin to boost immune responses - failed ... outbreaks. Last year, Sanofi set up an alliance with Immune

  • Sanofi to work with Immune Design on herpes vaccine Sanofi to work with Immune Design on herpes vaccine

    Sanofi has joined forces with US biotech Immune Design to accelerate development of the first therapeutic vaccine against genital herpes. ... Sanofi vaccines division Sanofi Pasteur and Immune Design both have candidates in early-stage testing but have

  • Merck Serono enters anti-PD-1 fray Merck Serono enters anti-PD-1 fray

    MSB0010718C blocks the interaction of PD-L1 with its receptor PD-1 and may have the potential to restore effective anti-tumour immune responses, according to Merck Serono.  . ... Meanwhile, OncoSec Medical which has an intratumoral immunotherapy for MCC

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics